Search

everythinglearnresearchcommunity

for

Search:↓

Some men with early hair loss may have similar hormonal changes to women with Polycystic ovary syndrome, and could be at risk for developing type 2 diabetes.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Higher androgen levels do not cause baldness in men.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Removing both ovaries treated the woman's excess male hormone symptoms.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Hair loss improved with treatment and successful transplant.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Post-implantation erythema is a red skin condition after medical device implantation that sometimes goes away on its own.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.